Perspective: Vitamin C, ACSL4 and proposed ferro-aging in primate studies
A perspective proposes an iron-driven 'ferro-aging' trajectory orchestrated by ACSL4 and discusses whether vitamin C, at supraphysiological concentrations, might inhibit ACSL4; primate evidence is emerging, the mechanism is unconfirmed and human benefit unvalidated. [1]
Automatic summary · not editorially reviewed
The key findings
Ferro-aging is proposed as an evolutionarily conserved, iron-driven aging trajectory orchestrated by ACSL4, linking lipid peroxidation, cellular senescence and systemic organ decline in primates. [1]
Emerging non-human primate evidence suggests vitamin C has been proposed to inhibit ACSL4 at supraphysiological concentrations, potentially reversing multi-omic markers of biological age and preserving neural and metabolic measures in aged individuals. [1]
The precise molecular mechanism of vitamin C-mediated ACSL4 inhibition remains unconfirmed, and the geroprotective efficacy of vitamin C in humans is yet to be validated. [1]
The source at a glance
- Study type / format
- Perspective article (abstract)
- Population / context
- Primates, including non-human primates and aged individuals; human efficacy not yet validated
- Summary based on
- Study abstract
- Original publication
- June 26, 2026
Proposed ferro-aging concept in primates
The source describes ferro-aging as a proposed, evolutionarily conserved, iron-driven aging trajectory orchestrated by ACSL4 (acyl-coenzyme A synthetase long-chain family member 4). This proposed axis is said to link lipid peroxidation, cellular senescence and systemic organ decline in primates. The text presents this as a concept, not an established mechanism.
Supporting source [1]
Vitamin C and ACSL4 in aged primates
According to the source, emerging evidence from non-human primate studies suggests that vitamin C, traditionally viewed as a broad-spectrum antioxidant, has been proposed to interact with and inhibit ACSL4 activity at supraphysiological concentrations. This is described as potentially reversing multi-omic markers of biological age and preserving neural architecture, functional connectivity and metabolic homeostasis in aged individuals. These are proposed possibilities, not demonstrated human outcomes.
Supporting source [1]
Unconfirmed mechanism and unvalidated human efficacy
The source states that the precise molecular mechanism of vitamin C-mediated ACSL4 inhibition remains unconfirmed. It also states that the geroprotective efficacy of vitamin C in humans is yet to be validated. The perspective critically discusses the mechanistic basis of the vitamin C–ACSL4–ferro-aging axis, examines key limitations of current evidence and highlights translational potential and unresolved challenges of targeting ferro-aging for healthy aging.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The source is a perspective, not a primary study. Primate findings are described as emerging, the molecular mechanism is unconfirmed and human geroprotective efficacy is unvalidated.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Li C, Gong Z, Ye J, Ni Y. · europepmc.org · June 26, 2026